Advertisement
U.S. markets closed

Regencell Bioscience Holdings Limited (RGC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
6.10+0.17 (+2.87%)
At close: 04:00PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 76.84M
Enterprise Value 68.97M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)9.35
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -44.58

Trading Information

Stock Price History

Beta (5Y Monthly) -0.60
52-Week Change 3-45.32%
S&P500 52-Week Change 331.45%
52 Week High 332.44
52 Week Low 33.03
50-Day Moving Average 35.93
200-Day Moving Average 35.85

Share Statistics

Avg Vol (3 month) 3107.96k
Avg Vol (10 day) 387.37k
Shares Outstanding 513.01M
Implied Shares Outstanding 613.01M
Float 81.44M
% Held by Insiders 188.82%
% Held by Institutions 10.19%
Shares Short (Oct 31, 2024) 462.16k
Short Ratio (Oct 31, 2024) 40.31
Short % of Float (Oct 31, 2024) 42.56%
Short % of Shares Outstanding (Oct 31, 2024) 40.48%
Shares Short (prior month Sep 30, 2024) 47.83k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-28.11%
Return on Equity (ttm)-43.18%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -4.43M
Net Income Avi to Common (ttm)-4.3M
Diluted EPS (ttm)-0.33
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.96M
Total Cash Per Share (mrq)0.61
Total Debt (mrq)85.74k
Total Debt/Equity (mrq)1.04%
Current Ratio (mrq)41.92
Book Value Per Share (mrq)0.63

Cash Flow Statement

Operating Cash Flow (ttm)-4M
Levered Free Cash Flow (ttm)-1.88M